tirzepatide head to head semaglutide SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Tirzepatide vs Semaglutide: What's the

This means less degradation, less first-pass metabolism, and a far more direct route to the bloodstream

Semaglutide is one of the most studied and widely prescribed GLP-1 medications available

However, when we submit supporting records or lab results, were typically able to get it approved on appeal. Some Aetna plans require step therapy before the insurance company will approve a prescription for Jardiance

This is felt to be due to the detoxification effect of B12 in patients who have methylation issues

doi:10.1038/nrendo.2015.3 13

Co-first authors Dylan Rausch, Mette Ludwig and Marie Aare Bentsen from Novo Nordisk A/S are all CBMR alumni